Drugs / TR-012001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06212089 | Sep 2023 → Apr 2024 | Parkinson disease | SNLD, Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TR-012001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06212089 ↗ |